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Abstract 
Neonatal respiratory distress syndrome (RDS) is related with 
high mortality and morbidity in preterm infants and the best 
approach to treat it is an open research field. The use of 
perfluorocarbons (PFC) together with non-invasive respiratory 
support techniques, such as nasal continuous positive airway 
pressure (CPAP), has confirmed its effectiveness to achieve a 
more homogeneous surfactant distribution. The goal of the 
current study was to evaluate the main features of the aerosol 
generated by an intracorporeal inhalation catheter, which 
consists of one central lumen delivering the liquid and six 
peripheral lumens delivering compressed air. Firstly, 
experiments were made through an Aerodynamic Particle Sizer 
(APS) with sterile water and perfluorocarbon FC75 with a 
driving pressure of 4 bar to analyze properties linked with lung 
deposition such as the aerodynamic diameter (Da), mass median 
aerodynamic diameter (MMAD) and geometric standard 
deviation (GSD). Subsequently, a numerical model was 
developed with CFD techniques. The experimental validation of 
the numerical model provides an accurate prediction of the air 
flow axial velocity. 
1. Introduction
Extremely and very preterm infants present cerebral and 
pulmonary issues due to the immaturity of the lungs, 
primarily caused by the lack of surfactant. This leads to 
the Respiratory Distress Syndrome (RDS) of the 
newborn, which is the leading cause of death in premature 
babies [1]. This natural substance covers the alveoli, its 
main goal being to reduce the surface tension and, 
therefore, to prevent alveolar collapse at the end of the 
exhalation, retaining enough air to start the next breath. 
The current surfactant replacement therapy implies some 
drawbacks, as the requirement of intubation and the 
application of ventilator support techniques, which can 
result in lung injury and chronic lung diseases (CLD) [2]. 
In this regard, the neonatologists are focused on new 
minimally invasive surfactant therapies (MIST) as an 
alternative to solve the current dilemma; how to deliver 
exogenous surfactant without invasive techniques when 
the application of continuous positive airway pressure 
(CPAP) is not enough [3]. 
The administration of nebulized surfactant is a promising 
technique to treat lung diseases and especially RDS, even 
though there are still technical issues and challenges to 
lead. Four clinical trials have been published showing that 
is a feasible and safe technique. However, only one of 
them [4] has demonstrated good results. Currently, Pillow 
and Minocchieri are working on a new clinical trial, the 
CureNeb study, where preterm infants receive either 
CPAP or CPAP and nebulized surfactant in the first 4 
hours of life [5]. Another alternative is the use of 
perfluorocarbons (PFC). Burkhardt et al. [6] have 
demonstrated that is useful to improve surfactant 
distribution and that resulted in an improved oxygenation. 
One of the main reasons of the low efficiency of 
nebulized surfactants in these clinical trials is the relative 
low lung deposition rates (less than 1% of the mass 
nebulized) with conventional jet and ultrasonic 
nebulizers. Nevertheless, Goikoetxea et al. [7] have 
studied the potential to deliver relatively large amounts of 
surfactants and perfluorocarbons beyond the third 
generation of branching in a neonatal airway model 
through an intracorporeal inhalation catheter (IC). The 
influence of four different ventilation strategies on 
surfactant and PFC aerosol production rate were studied 
in an in vitro study by Murgia et al. [8]. The results 
showed that higher peak inspiratory pressure (PIP) and 
higher respiratory rates (RR) might enhance surfactant 
and PFC delivery to the lungs but might also increase 
compound loss during expiratory phase. 
Numerical models through Computational Fluid 
Dynamics (CFD) techniques provide a useful 
methodology to study the behavior of aerosol particles in 
the airways and to obtain valuable data related with 
airflow patterns, particle deposition and particle size 
distributions. Recently, Goikoetxea et al. [9] evaluated 
with a numerical model the aerosol delivery of surfactant 
and perfluorodecalin (PFD) by means of an inhalation 
catheter (IC). The results showed the beneficial effects of 
generating an intracorporeal aerosol with minimal airway 
manipulation. 
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 2. Experimental Setup 
An inhalation catheter (IC) (AeroProbe, Trudell Medical 
International), illustrated in Fig. 1, was used to produce 
the aerosol. Sterile water (H2Od) has been used to 
simulate the nebulization. The compressed air is delivered 
through six peripheral lumens and the liquid is delivered 
through the central lumen. The close proximity of these 
lumens at the catheter tip results in efficient 
aerosolization of the liquid. Additionally, the 
perfluorocarbon (PFC) compound FC-75 (C8F16O) has 
been tested. 
 
Figure 1. Inhalation catheter (IC 1.1) 
An Aerodynamic Particle Sizer (APS 3321) has been 
used, which provides high-resolution of particles from 0.5 
to 20 µm. The IC has been connected to a pressure control 
system, which allows to change the driving pressure 
between 0-7 bar. The scheme of Fig. 2 shows the 
equipment and experimental setup used to study the 
aerosol formation. The distal end of the IC has been 
aligned with the nozzle of the APS in order to obtain an 
accurate measurement of the aerosol generated and 
different distances between the distal end of the IC and 
the nozzle has been set to check the concentration of the 
aerosol. Even though the usable data of the APS is up to 
10.000 particles/cm3, the average recommended particle 
concentration is 1000 particles/cm3 
 
Figure 2.  Experimental setup 
3. Experimental results 
Both compounds were studied with a driving pressure of 
4 bar, as can be seen in Tables 1-2. Five samples were 
recorded for each case, with a sample time of 10 seconds. 
At first, it was necessary to establish the optimal distance 
between the catheter tip and the APS nozzle in order to 
obtain accurate measurements. It was found that the 
optimal distance were 42 cm and 5.2 cm for the sterile 
water (H2Od) and the FC-75 respectively. 
Sample Da 
(µm) 
MMAD 
(µm) 
GSD Concentration 
(particles/cm3) 
16 4.00 10.3 2.20 1040 
17 4.09 10.3 2.19 1210 
18 4.08 10.1 2.15 1240 
19 4.12 9.89 2.14 1060 
20 4.01 10.2 2.21 1050 
MEAN 4.06 10.16 2.18  
SD 0.05 0.17 0.03  
Table 1. Experimental results with sterile water 
The same procedure was carried out with the FC-75 
compound with a driving pressure of 4 bar and its optimal 
distance. This data were used to validate the results of the 
numerical model. 
Sample Da 
(µm) 
MMAD 
(µm) 
GSD Concentration 
(particles/cm3) 
1 2.47 10.5 1.70 1140 
2 2.45 10.1 1.69 1160 
3 2.44 10.3 1.70 1190 
4 2.45 9.73 1.68 1210 
5 2.43 9.42 1.68 1140 
MEAN 2.45 10.01 1.69  
SD 0.01 0.44 0.01  
Table 2. Experimental results with FC75 compound 
The geometric standard deviation (GSD), the mass 
median aerodynamic diameter (MMAD) and the 
aerodynamic diameter (Da) have been analyzed to study 
the particle size characterization. The GSD is a 
dimensionless number which gives an indication of the 
spread of sizes of particles that make up the aerosol. An 
aerosol is made up of particles of many different sizes 
(heterodisperse aerosol) with a GSD above 1.25. On the 
other hand, a GSD below 1.25 indicates that all the 
aerosol particles are of the same or very nearly the same 
size (monodisperse aerosol). The MMAD is defined as 
the value of the aerodynamic diameter (Da) such that half 
the mass of the aerosol is contained in small diameter 
particles and half in larger. The relationship between the 
aerodynamic particle diameter (Da) measured by the APS 
and the geometric particle diameter (Dg) is given by (1):  
ρ
ρ0
ag DD =
 
where ρ0 is the unit density (1 g/cm3) and ρ the density of 
the compound to be nebulized, in this case ρ =0.9982 
g/cm3 for the sterile water and ρ =1.78 g/cm3 for the FC75 
compound. 
4. Numerical model 
In the work presented in this study the commercial CFD 
code Star CCM+ version 11.06 (CD Adapco®) was used 
to create and run the numerical model. The problem was 
simplified making an axisymmetrical assumption to 
define the computational domain in order to save 
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 computational time in the simulation of the discrete 
particles. In this case, the six outer lumens are replaced by 
a ring, as shown in Fig. 4. The position of the air lumen 
(blcen) was maintained and the width of the ring was 
calculated by (3-5) in order to have the same area of the 
six outer lumens and consequently, the same air mass 
flow. The computational domain consists of the last 2 mm 
of the catheter and the downstream region beyond the 
catheter tip, as illustrated in Fig. 3. The outlet is located 
52 mm away from the catheter tip, which is the optimal 
distance used for the experimental measurement of the 
FC-75 particle size distribution with the APS. 
 
Figure 3. Computational domain and boundary conditions 
An air mass flow rate of 1.1344x10-5 kg/s, measured in a 
previous work with a driving pressure of 4 bar [7], was 
defined as the inlet boundary condition along with a 
temperature of 293K and a turbulence intensity of 0.07. 
An atmospheric outlet boundary condition was fixed for 
downstream boundaries and the axisymmetrical condition 
was set to the central axis. Ten particle injections were 
defined, as can be seen in Table 3, to represent the 
particle size and mass distribution. The injection line was 
defined 2 mm away from the catheter tip as an estimated 
value between the APS nozzle and the laser beams which 
measures the distribution of the particles. 
Injection  Dg (µm) Mass flow rate (kg/s) 
1 0.392 3.41·10-8 
2 0.604 2.68·10-8 
3 0.866 3.17·10-7 
4 1.335 2.41·10-7 
5 1.910 6.88·10-7 
6 2.945 1.20·10-5 
7 4.535 6.31·10-6 
8 6.495 1.55·10-6 
9 10.000 1.61·10-6 
10 14.850 4.90·10-7 
Table 3. Particle initial conditions obtained from experimental 
measurements 
5. Numerical results and experimental 
validation 
The continuity and Navier-Stokes equations are solved for 
the continuous phase (air) and the Newton’s second law 
of motion is solved for the dispersed liquid droplets. Once 
the steady state air solution is converged the discrete 
phase was added by injection points defined within a line 
and simulated in transient state. 
Fig. 4 illustrates the air flow velocity once the solution 
was converged. The highest value was reached close to 
the outlet of the catheter tip with a peak of 385 m/s. The 
velocity value 2 mm away from the outlet, where the 
injectors were defined, was 238 m/s [10]. 
 
 
Figure 4. Continuous phase velocity magnitude and particle size 
distribution of the discrete particles 
The axial velocity at different distances beyond the 
catheter tip were taken and validated with experimental 
data by means of a hot-wire constant temperature 
anemometer (Goikoetxea et al. [9]). The Realizable K-
epsilon model used in the numerical model provides an 
accurate prediction of the air flow (See Fig.5). 
 
Figure 5. Experimental and numerical axial air velocity profiles 
6. Trachea digitalization 
A surface model was needed to perform the CFD 
analysis, so three tracheal segments from pigs were 
digitized. Initially, the pieces required to be divided in 
order to scan their interior. The cut would deform its inner 
shape due to the soft organic tissue composition of the 
tracheas. To minimize this situation, the exterior of the 
parts were previously scanned and two rigid plastic shells 
were prototyped from the surface. With the shells 
wrapping the tracheal segments, they were cut off, as 
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illustrated in Fig.6a. These housings fix the outer shape 
and minimize deformation inside the tracheal segment. 
The inner surface was scanned by structured blue light to 
filter out interfering ambient light. Afterwards, the point 
clouds were treated and optimized (See Fig.6b). In each 
case the two halves were joined together using the initial 
scan and shells as reference and exported to a format 
understandable for the CFD software (See Fig.6c). The 
task was carried out by the ATOS Compact Scan M5 ™ 
hardware, from GOM mbH manufacturer, and by the 
Geomagic Design X software, from 3D Systems 
Corporation. 
Figure 6. Process of trachea digitalization 
Once the geometry was imported to the CFD code, the 
trachea segment was modified to add the catheter tip. An 
unstructured polyhedral mesh with 1.5 million cells was 
used in the domain, as shown in Fig. 7. 
Figure 7. Mesh distribution of the geometry with the catheter tip 
An air mass flow rate of 1.1344·10-5 kg/s was defined as 
the inlet boundary condition to study the distribution of 
the velocity airflow through the trachea.  
Figure 8. Numerical simulation of the air inside the trachea 
7. Conclusions
The aerodynamic diameter (Da) measured was between 
the optimal recommended values (1-5 µm) and even 
though the MMAD is around 10 µm the study is focused 
to generate the aerosol beyond the nasopharyngeal area, 
avoiding the deposition of big particles. Further work is 
necessary to implement the numerical model presented 
above to study the aerosol generated in the trachea. 
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